LTI-291
LTI-291 is a glucocerebrosidase (Gcase) activator for treatment of Parkinson's disease (PD) .
Product Specifications
CAS Number
1919820-28-2
Product Name Alternative
LTI-291 | LTI 291 | LTI291
Purity
>98% (HPLC)
Solubility
DMSO : 50 mg/mL 139.48 mM
Smiles
O=C (C1=C2N=C (C) C=C (C) N2N=C1) N[C@H]3CC[C@H] (OCCCCC) CC3
Molecular Formula
C20H30N4O2
Molecular Weight
358.49
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
5,7-Dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (trans-4-pentyloxy-cyclohexyl) -amide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
038165-PE 200 µL
Mapk10, NT (Mapk10, Jnk3, Prkm10, Serk2, Mitogen-activated protein kinase 10, MAP kinase p49 3F12, Stress-activated protein kinase JNK3, c-Jun N-terminal kinase 3) (PE) discontinued
Sign In for Pricing
View Details 
MBS1387509-01 0.02 mg (E-Coli)
Recombinant Haemophilus somnus Crossover junction endodeoxyribonuclease RuvC (ruvC)
Sign In for Pricing
View Details MBS1387509-02 0.1 mg (E-Coli)
Recombinant Haemophilus somnus Crossover junction endodeoxyribonuclease RuvC (ruvC)
Sign In for Pricing
View Details